Company Description or Summary:

Chiima Therapeutics is a pre-clinical early-stage biotech company committed to changing the chronic and acute pain treatment landscape. The current focus is on developing early-stage molecules that deliver safe, effective, and easy-to-use therapeutic compounds for acute and chronic pain. We are currently investigating our lead compound CHM-001 for treatment in local analgesic treatment in endometriosis-related pain in adult women. Endometriosis-related pain is a serious concern.